InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Pamir Ozan. Officer active across 3 companies, notably 180 Life Sciences Corp.. Aggregated, 5 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €51k. History available since 10 December 2021. The latest transaction was disclosed on 30 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
4,255 shares@ US$2.71Common StockSEC:0001834681-26-000001:0
2,907.197 shares@ US$7.36100.0% of flowCommon StockSEC:0001628280-24-049079:0
Ideal exit: 19 Aug 2025 (T+270)
5,162.077 shares@ US$1.0115.7% of flowCommon StockSEC:0001213900-23-041328:0
Ideal exit: 12 Feb 2024 (T+270)
3,800 shares@ US$3.8750.0% of flowCommon StockSEC:0001213900-21-064876:0
Ideal exit: 6 Sept 2022 (T+270)
3,800 shares@ US$3.8742.2% of flowCommon StockSEC:0001213900-21-064876
Ideal exit: 6 Sept 2022 (T+270)
5 of 5 declarations
About Pamir Ozan
Pamir Ozan is a declarant linked to 180 Life Sciences Corp. and ChromaDex Corp., where the listed roles are CFO and Chief Financial Officer. In the sampled filings, all transactions are acquisitions, totaling EUR 51320, between 2021-12-13 and 2024-11-25, and the total number of filings is 4.
